Inventor
FALK RUDOLF EDGAR
CA29 patents
⚠️ This page may combine multiple inventors who share the name “FALK RUDOLF EDGAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HYAL PHARMA CORP
27 patentsUS6069135AMay 30, 2000
Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents
HYAL PHARMA CORP87 citations99
US6194392B1Feb 27, 2001
Treatment of conditions and disease
HYAL PHARMA CORP41 citations96
US6048844AApr 11, 2000
Treatment of conditions and disease
HYAL PHARMA CORP54 citations96
US5985851ANov 16, 1999
Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
HYAL PHARMA CORP25 citations96
US5929048AJul 27, 1999
Treatment of conditions and disease
HYAL PHARMA CORP34 citations96
US5914314AJun 22, 1999
Use of a form of hyaluronic acid and a medicinal agent for reducing rejection of organs transplantation in mammals
HYAL PHARMA CORP21 citations96
US5852002ADec 22, 1998
Treatment of conditions and disease
HYAL PHARMA CORP46 citations96
US5830882ANov 3, 1998
Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
HYAL PHARMA CORP34 citations96
US5827834AOct 27, 1998
Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
HYAL PHARMA CORP54 citations96
US5824658AOct 20, 1998
Topical composition containing hyaluronic acid and NSAIDS
HYAL PHARMA CORP70 citations96
US5811410ASep 22, 1998
Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID
HYAL PHARMA CORP49 citations96
US5639738AJun 17, 1997
Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
HYAL PHARMA CORP56 citations96
US6022866AFeb 8, 2000
Use of hyaluronic acid and forms to prevent arterial restenosis
HYAL PHARMA CORP81 citations95
US6103704AAug 15, 2000
Therapeutic methods using hyaluronic acid
HYAL PHARMA CORP25 citations92
US6017900AJan 25, 2000
Topical composition containing hyaluronic acid and nsaids
HYAL PHARMA CORP28 citations92
US5962433AOct 5, 1999
Topical composition containing hyaluronic acid and NSAIDS
HYAL PHARMA CORP22 citations92
US5932560AAug 3, 1999
Treatment of conditions and disease
HYAL PHARMA CORP20 citations92
US5914322AJun 22, 1999
Treatment of disease and conditions
HYAL PHARMA CORP44 citations92
US5910489AJun 8, 1999
Topical composition containing hyaluronic acid and NSAIDS
HYAL PHARMA CORP40 citations92
US5834444ANov 10, 1998
Hyaluronic acid and salts thereof inhibit arterial restenosis
HYAL PHARMA CORP22 citations92
US5792753AAug 11, 1998
Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
HYAL PHARMA CORP44 citations92
US5674857AOct 7, 1997
Use of hyaluronic acid to repair ischemia reperfusion damage
HYAL PHARMA CORP25 citations92
US6114314ASep 5, 2000
Formulations containing hyaluronic acid
HYAL PHARMA CORP31 citations91
US5990095ANov 23, 1999
Use of hyaluronic acid and forms to prevent arterial restenosis
HYAL PHARMA CORP24 citations89
US5972906AOct 26, 1999
Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
HYAL PHARMA CORP35 citations89
US5847002ADec 8, 1998
Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID
HYAL PHARMA CORP25 citations89
US5817642AOct 6, 1998
Clearing of atherosclerosis
HYAL PHARMA CORP15 citations74